GLP-1 agonists may be preferable in some elderly patients due to lower hypoglycemia risk, though GI side effects and potential for weight loss (which can be undesirable in frail elderly patients) require careful consideration
Synthesis, structure and biological activity of a new and efficient cd (II)uracil derivative complex system for cleavage of DNA
Tuy nhin, nu bn c tin s d ng hoc nhy cm vi bt k th nh phn n o ca sn phm, c th gp phn ng nh nh kch ng d d y
, Glucagon-like peptide-1 therapy in people with obesity restores natural killer cell metabolism and effector function, Obesity , vol
Ci thin sc khe tim mch Cc nh nghin cu cho rng, vic s dng Nattokinase c th gip ngn nga cc cn au tim, ci thin sc khe tim mch nh: H huyt p: Cc nghin cu cho thy nattokinase gip h c huyt p tm thu v huyt p tm trng nhng ngi b tng huyt p ( huyt p cao )
Follow-up visit: During the IV/IM therapy plan, a follow-up visit is arranged with the healthcare Prescriber to assess progress on the treatment/ therapy plan, make any necessary adjustments if necessary, and provide ongoing support and guidance
.png)
